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Background. Late-life depression (LLD) is associated with a decline in physical activity. Typically this is assessed by self-
report questionnaires and, more recently, with actigraphy. We sought to explore the utility of a bespoke activity monitor
to characterize activity profiles in LLD more precisely.
Method. The activity monitor was worn for 7 days by 29 adults with LLD and 30 healthy controls. Subjects underwent
neuropsychological assessment and quality of life (QoL) (36-item Short-Form Health Survey) and activities of daily living
(ADL) scales (Instrumental Activities of Daily Living Scale) were administered.
Results. Physical activity was significantly reduced in LLD compared with controls (t = 3.63, p < 0.001), primarily in the
morning. LLD subjects showed slower fine motor movements (t = 3.49, p < 0.001). In LLD patients, activity reductions
were related to reduced ADL (r = 0.61, p < 0.001), lower QoL (r = 0.65, p < 0.001), associative learning (r = 0.40, p = 0.036),
and higher Montgomery–Åsberg Depression Rating Scale score (r =−0.37, p < 0.05).
Conclusions. Patients with LLD had a significant reduction in general physical activity compared with healthy controls.
Assessment of specific activity parameters further revealed the correlates of impairments associated with LLD. Our study
suggests that novel wearable technology has the potential to provide an objective way of monitoring real-world function.
Received 18 March 2016; Revised 1 August 2016; Accepted 2 August 2016; First published online 26 September 2016
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Introduction
There is an important, bidirectional relationship be-
tween physical activity and late-life depression
(LLD), with evidence that LLD is associated with
impairments in activities of daily living (ADL) and a
reduction in gross physical activity. It has also been
consistently demonstrated that LLD is associated
with psychomotor slowing, widespread cognitive
impairments (that can persist despite clinical recovery),
reduced quality of life (QoL) and structural brain
changes, including an increase in white matter lesions
(Colloby et al. 2011). However, the extent to which
changes in ADL and QoL, imaging abnormalities and
cognitive impairments demonstrated in clinical/labora-
tory settings relate to depression and physical activity
in LLD in the real world remains unclear. The major
barrier to elucidating the nature of this relationship
has been devising an acceptable and validated way
of accurately measuring activities in the real world
on an ongoing basis, especially in those with depres-
sion. While activity levels have been measured using
wrist- and chest-worn actigraphs in younger depressed
subjects (Burton et al. 2013), few previous studies have
specifically examined the utility of these devices to the
assessment of community-dwelling older depressed
subjects. Furthermore, while the use of actigraphy to
assess day-to-day physical activity has great potential,
there are important limitations to the interpretability of
the data they produce due to a lack of agreement as
what constitutes light/moderate/intense activity in
older adults and the likelihood that these arbitrary
categorizations reduce data fidelity (van Hees, 2012;
Kim et al. 2013a). Through the rapid development of
this technology, it has been suggested that far more in-
sightful comparisons can be drawn by utilizing ana-
lysis of raw output from accelerometers (i.e. direct
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sensor readings), rather than the categorical data
derived from actigraphy (i.e. aggregated epoch values
such as step counts etc.; Sabia et al. 2014). Therefore, in
this study we sought to develop and collect feasibility
data from a novel wrist-worn device that, unlike an
actigraph, allows the analysis of direct sensor readings.
Using these readings, we sought to characterize
fine-detail activity levels in depressed subjects and
healthy comparison subjects. Our primary hypothesis
was that gross measures of physical activity would
be reduced in LLD patients compared with healthy
controls. We further hypothesized that analysis of
raw accelerometer data would demonstrate altered
movement signatures in LLD patients. Based on ana-
lysis of raw accelerometer data, our exploratory hy-
potheses were that 24 h patterns of fine-grained
physical activity in the real world would correlate
with measures of social function, ADL, QoL, neuro-
psychological function, severity of depression and
magnetic resonance (MR)-derived measures of region-
al brain volumes.
Method
Participants
A total of 29 participants aged over 60 years and who
fulfilled Diagnostic and Statistical Manual of Mental
Disorders, 4th edition (DSM-IV) criteria for current major
depression, as assessed using the Mini-International
Neuropsychiatric Interview (M.I.N.I.; Sheehan et al.
1998), were recruited from secondary care services cover-
ing four geographically based secondary catchment
areas across the North East of England. A comparison
group (n = 30) of similarly aged controls with no self-
reported history of depression or current depression as
measured using the M.I.N.I were recruited. These came
predominantly from a volunteer database maintained by
the North East England Clinical Research Network.
Individuals with evidence of a severe or unstable physical
illness (e.g. recent significant cardiac events, insulin-
dependent diabetes mellitus, untreated hypothyroidism,
cancer), known cognitive impairment or dementia, Mini
Mental State Examination (MMSE; Folstein et al. 1975)
score <24, acquired brain injury or stroke were excluded
from the study. Other exclusion criteria were: recent his-
tory or current evidence of substance abuse (e.g. alcohol,
drugs); uncorrected visual or auditory sensory deficits;
and history of electroconvulsive therapy (ECT) in the
past 6months (clinical sample) or any history of ECT (con-
trol sample). All participants had English as a first lan-
guage. The National Research Ethics Service committee
for the North East of England approved the study. All
patients and controls gave written informed consent to
participate after the study protocol had been fully
explained.
Materials
The wearable monitor was a stand-alone, wrist-
mounted device that recorded physical activity via
three accelerometers. The device was designed to be
as unobtrusive as possible to minimize non-adherence
and to allow the capture of raw data from a naturalistic
environment (Fig. 1). The study device†1 included a tri-
axial accelerometer, internal data storage and a lithium
ion battery lasting for a mean duration of 5 days. These
instruments, their controllers and the accompanying
printed circuit board were encased in a thermoplastic
housing, which was then injected with a resin com-
pound to ensure water resistance. The device itself
was held by an adjustable silicone wristband, with a
stainless-steel fastening mechanism to allow for com-
fortable, hypoallergenic, wrist-mounted use.
Procedure
Consenting eligible participants were screened at a base-
line assessment during which demographic information
and self-report histories of current medication, physical
and mental health were recorded. Assessments included:
the M.I.N.I., the Montgomery–Åsberg Depression Rating
Scale (MADRS; Montgomery & Åsberg, 1979); the
15-item Geriatric Depression Scale (GDS-15; Sheikh &
Yesavage, 1986); the MMSE; the National Adult
Reading Test (NART; Nelson, 1982) and the Edinburgh
Handedness Inventory (Oldfield, 1971). Participants
received three further visits, all of which took place in
their homes. On day 1, the study device was delivered.
Assessments of mood (MADRS and GDS-15) were
Fig. 1. The wearable monitor.
† The notes appear after the main text.
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repeated along with measures of social functioning and
physical/mental wellbeing: Short-Form Health Survey
(SF-36; Ware & Sherbourne, 1992) and Instrumental
Activities of Daily Living Scale (IADL; Lawton &
Brody, 1969). Because the device battery life was less
than the 7-day study period, between days 2 and 6 the
initial study device was swapped for a second, identical,
fully charged device at a home visit. After a full 7 days,
the study device was collected and assessments of mood
(MADRS and GDS-15) were repeated.
Neuropsychological assessment
Subjects underwent a comprehensive neuropsychological
test battery during the study period consisting of: a digit
span (DS) task, a digit symbol substitution task (DSST),
a computer-administered facial emotion processing task
(FERT; Adams et al. 2015), the two-part Trail Making
task (TMA, TMB), the Rey Auditory Verbal Learning
task (RAVL), the FAS verbal fluency task (FAS), and
four tasks from the Cambridge Neuropsychological Test
Automated Battery (CANTAB): paired associates learn-
ing (PAL), spatial span (SSP), spatial working memory
(SWM), affective go/no-go (AGN). Pen-and-paper tasks
were administered according to standardized instruc-
tions. CANTAB tasks were carried out according to the
protocol manual on a laptop fitted with a 12.5” colour
touchscreen.TheFERTwascarriedouton thesamelaptop
using the attached keyboard modified with labels for the
target emotions.
MR imaging (MRI) scanning protocol
All eligible subjects were offered participation in the MRI
substudy. In all, 15 patients and 15 controls underwent a
3-Tesla MRI scan on a Philips Achieva clinical MR sys-
tem using an eight-channel head coil. This included
T1-weighted whole brain magnetization-prepared rapid
gradient-echo (MPRAGE) images acquired in the sagittal
plane (repetition time = 8.3 ms, echo time = 4.6 ms, flip
angle = 8°, inversion delay = 1250 ms, 216 × 208 matrix,
slice thickness = 1.0 mm) yielding 180 slices through the
brain. A fluid attenuated inversion recovery (FLAIR) se-
quence (repetition time = 11 000 ms, echo time = 125 ms,
inversion recovery = 2800 ms, turbo spin echo factor =
27; refocus angle = 120°, slice thickness = 3 mm) yielded
50 slices through the brain. MR images were processed
using SPM8 (http://www.fil.ion.ucl.ac.uk/spm/) and
Matlab 2012b (MATLAB6.1; The MathWorks Inc.,
USA). Hippocampal volumes were measured using an
automated segmentation technique (Firbank et al. 2008).
Volumetric measurements of white matter hyperinten-
sity (WMH) were obtained for each individual using a
previously validated method (Firbank et al. 2004).
Data analysis
Data were analysed with SPSS 21 (IBM Corp.; USA)
and R (http://www.R-project.org/). Q-q plots were
used to establish the normality of the data. Group dif-
ferences were assessed using independent t tests. To
militate against the problem of multiple comparisons
with the neuropsychological data, composite average
Z scores were created for five conceptual domains:
Executive working memory: total score from FAS
verbal fluency, total score from backward DS test, be-
tween errors (4–10 boxes) from CANTAB SWM.
Attention and psychomotor speed: trails A total
time, DSST total time.
Short-term memory: total score from forward DS
test, span length from CANTAB SSP.
General memory: total from RAVL presentations
1–5, maximum recall from delayed condition of
RAVL, total errors (adjusted) from CANTAB PAL,
standardized profile score from RMBT.
Emotional processing: median latency of correct
responses on the CANTAB AGN, proportion of correct
to incorrect answers from the FERT.
Patient data were cantered against control group Z
scores by subtracting the mean for control participants
from the raw score of each depressed patient then div-
iding the result by the standard deviation of the control
group. A grand mean Z score was calculated for
performance across all tests. Multivariate analysis, cov-
arying for NART intelligence quotient (IQ), was used
to assess group differences in domain scores and
missing values were imputed with group mean values.
Analysis of physical activity data from the study device
Pre-processing. Each recording from the study device
was subjected to pre-processing, comprising the follow-
ing steps: (i) autocalibration as described in van Hees
et al. (2014); (ii) interpolation of the recordings to a
frequency of 50 Hz using bi-cubic interpolation; (iii)
estimation of the acceleration magnitude; and (iv) band-
pass filtering to remove the effect of gravity using a
Butterworth filter with cut-off frequencies of 0.2 and
15 Hz, respectively. Finally, changeover days (when
participants were assisted in changing from one device
to the next) were combined into a single day.
Changeover typically lasted below 1 min, resulting in
minimal data loss. Wear-time was estimated using the
approach described in van Hees et al. (2011), where
each 30 min segment of recording is classified as ‘wear-
time’ if the standard deviation of the acceleration mag-
nitude exceeds a fixed threshold of 13mg (g = 9.81 m/s2).
Exclusion criteria for days of recording. A day of record-
ing from a participant qualified for further analysis if
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the device was worn for more than half the day, if the
device calibration was successful, and if malfunction-
ing could be ruled out (e.g. due to memory corrup-
tion). One recording from the control group was
excluded from analysis due to calibration failure to
leave 29 healthy control recordings. The majority of
first and last days of recordings were also excluded
as the device was worn for less than half the day. A
total of 171 days were included for the depressed
group (average 5.9 days per participant), and a total
of 210 days were included for the control group (aver-
age 7.2 days per participant). We observed high com-
pliance in both the depressed (92.2%) and the control
group (92.3%) on those days that were included in
the analysis.
Measures of physical activity. For each 1 min of recording
of a participant we extracted the following characteris-
tics (Godfrey et al. 2008): (i) ‘physical activity’ as the
mean acceleration magnitude, a measure for how
much, on average, the device was accelerated within
1 min; (ii) ‘jerk’ as the mean of the first derivative of ac-
celeration magnitude, estimated using a five-sample
linear regression. Jerk reflects the ‘suddenness’ of
movements, where ‘quick’ movements lead to a higher
jerk or change in acceleration over time; (iii) ‘entropy’
as the statistical entropy over the 1 min of acceleration
magnitude. Entropy is a measure for disorder that
reflects how ‘structured’ a movement is. Low entropy
is associated with stationarity, slow, and repetitive or
self-similar movements. High entropy is associated
with less predictable, more energetic movements like
gesturing.
Activity data analysis. Analysis of activity data was car-
ried out using Matlab 2015a (The MathWorks Inc.,
USA). We constructed an average day for each partici-
pant by estimating the mean of each of physical activ-
ity, jerk and entropy for the 1440 min in the day across
all days of recording. Non-wear time was excluded
from the calculation of the means for each minute.
Potentially confounding effects of age, body mass
index (BMI) and pre-morbid IQ were removed from
the estimated measures through a linear regression of
each variable with confounding variables. Only the
residuals of this regression were retained and added
to the overall mean, removing confounding effects in
the process. Group differences were assessed using
two-tailed independent t tests on the mean across the
average day. Further exploratory analysis was con-
ducted where the mean night-time activity (00.00–
06.00 hours) and mean daytime activity (06.00–24.00
hours) were correlated with key study variables
using partial correlation analysis.
Results
Subject characteristics
The groups did not differ significantly in age, sex or
living status, but there were group differences in pre-
morbid IQ, MMSE and BMI (Table 1). Subsequent ana-
lysis of neuropsychological data covaried for NART IQ
and correlations with physical activity data controlled
for age, sex, NART IQ and BMI.
Physical activity analysis
Mean 24-h activity (physical activity, jerk and entropy)
levels for LLD patients and healthy controls are shown
in Fig. 2. The difference in activity levels between the
groups is strongest in the morning and afternoon (06.00
to 18.00 hours), while they show similar activity levels in
the evening (18.00 to 00.00 hours). Fig. 3 illustrates the
relative frequency (distribution) of the means over all
minutes of the day for physical activity (a), entropy (b)
and jerk (c). Two-tailed t tests indicate that the two groups
show statistically significant differences (in mean) across
all investigated signal characteristics (p < 0.01).
Neuropsychological testing
There was a statistically significant group difference in
neuropsychological performance when NART IQ was
added as a covariate (F6,52 = 3.59, p < 0.005; Wilk’s Λ =
0.707). Table 1 illustrates that significant between-
subjects effects were observed for the Z-score domains
of executive/working memory, attention and psycho-
motor speed, memory and overall performance. No
significant difference was observed in short-term mem-
ory or emotional processing. For scores on individual
tests contributing to these domains, see online
Supplementary Table S1.
MRI analysis
Results of group contrasts for brain and structural
volumes are presented in Table 1. There were no signifi-
cant differences in whole-brain volume between the LLD
patients and the control participants. WMH volumes
were calculated as a ratio to intracranial volume and
log transformed to produce normally distributed data
for analysis. Depressed patients were found to have
significantly larger volumes of WMH than healthy con-
trols. Total hippocampal volumes were also calculated
as a ratio to intracranial volume: no significant differ-
ences were observed between LLD patients and controls.
Social functioning analysis
Results of group contrasts for scores on depression
scales repeated at each of the three study visits are pre-
sented in Table 1 along with scores for QoL and ADL. t
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Tests show significant group differences across all
measures, with the exception of the Duke Social
Support Index (DSSI) instrumental support measure,
which approached significance (t1,57 = 1.98, p = 0.053).
Correlation analysis
Based on significant group differences, we conducted
an exploratory analysis to assess the extent to which
key study variables correlated with movement data.
Fig. 4 illustrates partial correlations between these
key variables and physical activity for depressed
patients and healthy control subjects, accounting for
age, BMI, pre-morbid IQ and sex. Correlations with
SF-36 (Mental Health), PAL, IADL and MADRS scores
were at their strongest during waking hours (06.00 to
12.00 hours: SF-36, r = 0.65, p < 0.001, n = 29/29; PAL, r
= 0.40, p = 0.036, n = 28/23; IADL, r = 0.61, p < 0.001, n =
29/29; MADRS, r =−0.37, p < 0.05, n = 29/29). IADL
further showed strong correlations at night time
(r =−0.41, p = 0.026, n = 29/29). There were no signifi-
cant correlations between WMH and measures of
physical activity (e.g. correlation with daytime physic-
al activity; r =−0.063, p = 0.84, n = 13/14).
Table 1. Demographic characteristics and group comparisons
LLD patients Healthy controls Analysis
Mean (S.D.) n Mean (S.D.) n Statistics df p
Demographics
Age, years 74.0 (6.0) 29 73.9 (5.9) 30 t = 0.09 58 0.93
Female 21 22
Lives alone 18 12 χ2 = 2.9 1 0.09
Education, years 10.9 (2.2) 29 13.5 (3.3) 30 t =−3.47 57 <0.001
NART IQ score 109.0 (10.2) 29 114.5 (10.2) 30 t =−2.1 57 <0.05
MMSE score 27.7 (1.8) 29 28.9 (1.1) 30 t =−3.08 57 <0.005
Number of previous episodes 6.5 (13.0) 26
BMI, kg/m2 30.8 (6.8) 28 26.4 (3.9) 30 t = 3.05 55 <0.005
Neuropsychological Z scores
Executive working memory −1.2 (1.8) 29 0 (0.7) 30 F = 6.56 1,59 0.01
Attention and psychomotor speed −2.0 (2.8) 28 0 (0.9) 30 F = 11.09 1,59 <0.005
Short-term memory −0.5 (0.8) 29 0 (0.8) 30 F = 2.08 1,59 0.15
General memory −1.0 (1.1) 29 0 (0.8) 30 F = 11.1 1,59 <0.005
Emotional processing −0.1 (0.8) 28 0 (1.0) 29 F = 0.06 1,59 0.81
Grand score −0.9 (0.9) 29 0 (0.5) 30 F = 17.47 1,59 <0.001
MRI volumes
Proportion hippocampus to ICV 0.0036 (0.00065) 15 0.0037 (0.00058) 15 t = 0.4 28 0.68
Proportion WMH to ICV −2.1 (0.5) 13 −2.7 (0.7) 14 t =−2.5 25 0.02
Clinical scale scores
Baseline MADRS 28.1 (8.5) 29 1.0 (1.6) 30 t =−17.1 57 <0.001
Baseline GDS 9.7 (3.1) 29 0.8 (1.4) 30 t = –14.3 57 <0.001
DSSI instrumental support 18.5 (3.0) 29 19.9 (2.3) 30 t = 2.0 57 0.05
DSSI social support 41.7 (5.2) 29 48.4 (6.2) 30 t = 4.5 57 <0.001
IADL total score 6.9 (1.7) 29 8.0 (0.2) 30 t = 3.6 57 <0.001
SF-36 composite 38.3 (19.9) 29 79.2 (10.7) 30 t = 9.9 57 <0.001
LSNS-R total 25.5 (7.6) 29 36.9 (7.3) 30 t = 5.9 57 <0.001
UCLA Loneliness Scale total 18.5 (7.3) 29 5.6 (4.7) 30 t = –8.1 57 <0.001
Activity measures
Physical activity 0.17 (0.03) 29 0.20 (0.03) 29 t = 3.69 56 <0.001
Jerk 0.001 (0.0003) 29 0.001 (0.0002) 29 t = 4.06 56 <0.001
Entropy 2.50 (0.39) 29 2.81 (0.26) 29 t = 3.56 56 0.003
LLD, Late-life depression; S.D., standard deviation; df, degrees of freedom; NART, National Adult Reading Test; IQ, intelli-
gence quotient; MMSE, Mini Mental State Examination; BMI, body mass index; MRI, magnetic resonance imaging; ICV, intra-
cranial volume; WMH, white matter hyperintensity; MADRS, Montgomery–Åsberg Depression Rating Scale; GDS, Geriatric
Depression Scale; DSSI, Duke Social Support Index; IADL, Instrumental Activities of Daily Living Scale; SF-36, 36-item
Short-Form Health Survey; LSNS-R, Lubben Social Network Scale–Revised.
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Discussion
The present study utilized a novel wrist-worn device
to measure continuous physical movement activity ob-
jectively in older, community-dwelling adults with
LLD and healthy controls over a 7-day period. This is
the first study to characterize the quality of physical
movement in LLD patients using an objective measure.
Our results showed that patients with depression had
a significant reduction in general physical activity
Fig. 2. 7-Day mean physical activity, jerk and entropy across a 24 h period. LLD, Late-life depression.
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compared with healthy controls and this difference
was at its greatest during the morning and early after-
noon. Assessment of specific activity parameters
revealed that LLD patients showed ‘slowed’ fine
motor movements (measured by ‘jerk’) compared
with controls. Furthermore, these ‘slowed’ motor
movements can be characterized (by the measurement
of ‘entropy’) as being more repetitive and less likely to
represent gesturing in LLD patients.
Broader characterization of the groups revealed gen-
eralized neuropsychological dysfunction in the LLD
patients compared with controls along with increased
Fig. 3. Total wear time mean activity measures. LLD, Late-life depression.
Fig. 4. Correlation analysis between signal characteristics (mean over all days for each participant), and key study variables. r
Values for correlation strength and direction are given per group. * p < 0.05, ** p < 0.01. Patient data are presented with a solid
line of best fit, and controls with a dashed line of best fit. SF36, 36-Item Short-Form Health Survey; LLD, late-life depression;
co., controls; IADL, Instrumental Activities of Daily Living Scale; PAL, paired associates learning; act., activity; MADRS,
Montgomery–Åsberg Depression Rating Scale; WMH, white matter hyperintensity; ICV, intracranial volume.
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WMH burden on MRI. IADL and QoL were also sign-
ificantly reduced in LLD. Exploratory analyses demon-
strated that, after accounting for age, sex and BMI
differences, significant relationships were observed be-
tween selective movement parameters and aspects of
episodic memory (CANTAB PAL), IADL and QoL.
That the strongest relationships between key study
variables and movement were found when using ‘en-
tropy’ and ‘jerk’ indicates that future studies investi-
gating the relationship between physical activity and
LLD (or depression in general) may wish to utilize
raw accelerometer output, rather than abstracted mea-
sures of physical activity.
This study had several strengths, including using a
cohort of currently depressed community-dwelling
adults, the use of an unobtrusive, waterproof wrist-
worn activity monitor, and high levels of overall com-
pliance for wearing the device, coupled with the long
wear time (7 days).
Our study also had some limitations: we were not
able to obtain MR scans for all subjects. The study
was cross-sectional; hence we cannot determine causal-
ity in the relationship between physical activity and
the other key variables included in our comparisons.
It is important to bear in mind that some elements of
the relationship between physical functioning, depres-
sion and cognitive deficits may be bi-directional and
interrelated. For example, in community-dwelling,
healthy older adults, increased levels of daily physical
activity have been shown to be associated with
reduced depressive symptomatology (Vallance et al.
2011; Song et al. 2012; Kim et al. 2013b; Loprinzi,
2013), as well as reduced cognitive decline (Yaffe
et al. 2001). White matter integrity is also related to vas-
cular health and there is evidence that it relates to
levels of exercise (Burzynska et al. 2014). However,
we were not able to confirm a link between
fine-grained physical activity and WMH volumes in
this exploratory study.
Wearable accelerometers, such as the actigraph, pro-
vide more precise assessments of locomotor activity
and circadian rhythms in normal, everyday living
than traditional paper-based methods (Sabia et al.
2014) and the utility of these devices has been recog-
nized as a valid outcome measure for therapeutic inter-
ventions (Raoux et al. 1994; Winkler et al. 2014). The
novel, wearable sensing technology we utilized in
this work allowed the collection of precise data on a
continuous basis. The ability to interpret direct sensor
readings from a device recording continuous activity
data overcomes a number of limitations of previous
studies by allowing for objective assessment of move-
ment ‘quality’ rather than arbitrarily abstracting move-
ment data to ‘activity levels’. Previous studies in
related application fields have demonstrated that
more detailed movement analysis based on raw accel-
erometer data leads to improved outcome measures
(Matthews et al. 2012). Accessibility of raw sensor
recordings facilitates the application of sophisticated
computational analysis that goes beyond gross or
fine measures of movement, towards an understand-
ing of disease-specific idiosyncrasies in physical behav-
iour, for example: gait analysis (Lemke et al. 2000),
activity recognition (Bulling et al. 2014), automated
symptom assessment (Hammerla et al. 2015), analysis
of aggressive behaviour (Plötz et al. 2012), or skill as-
sessment (Khan et al. 2015). Whilst these data offer
huge potential as variables of interest, their utility
will depend on the extent to which they are feasible
and represent validated markers or surrogate markers
of the disease.
Wearable technology is a rapidly developing field
with implications for monitoring the long-term health
and recovery of people with depression. The results
of this study suggest that higher resolution analysis
of accelerometer-derived physical activity may provide
a suitable surrogate marker for depression in older
adults. Although compliance in this study was good,
further evidence is needed to assess the long-term ad-
herence for bespoke devices. While ADL and QoL
measures correlated well with physical activity, self-
report measures of loneliness and social support did
not, suggesting that other developing technologies
may be more appropriate for investigating the link be-
tween these variables in LLD. Furthermore, since exer-
cise has been proposed as a treatment for those with
depression, including LLD (Bridle et al. 2012; Cooney
et al. 2013; Mura & Carta, 2013), such devices may
play a role in monitoring levels of activity when used
therapeutically.
Supplementary material
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Supplementary Table S1
Demographics Mean SD n Mean SD n t df p
Age (years) 74.0 5.96 29 73.87 5.87 30 0.09 58 0.93
N (female) 21 22
Lives alone 18 12 2.40 1 n.s
Education (years) 10.90 2.24 29 13.47 3.32 30 -3.47 57 <0.001
Nart IQ score 109 10.26 29 114.53 10.26 30 -2.10 57 <0.05
MMSE Score 27.70 1.82 29 28.87 1.11 30 -3.08 57 <0.005
Number of previous episodes 6.50 12.97 26
BMI 30.85 6.79 28 26.42 3.94 30 3.05 55 <0.005
Neuropsych Mean SD n Mean SD n F df p
Digit forward 7.0 2.1 29 8.4 1.9 30 3.9 1,57 0.05
Digit backward 5.1 2.0 29 6.3 1.7 30 2.7 1,57 0.11
Digit total 12.1 3.4 29 14.7 3.0 30 4.9 1,57 0.03
Fluency total 37.8 13.2 27 50.0 14.6 30 2.9 1,57 0.10
Rivermead standardised score 14.8 5.9 19 18.6 2.8 20 4.9 1,36 0.03
Rivermead screening score 5.9 2.7 19 8.2 2.3 20 5.8 1,36 0.02
DSST symbol copy 265.1 126.6 23 189.4 43.7 27 5.1 1,47 0.03
DSST number copy 258.4 89.6 23 200.9 51.6 27 4.6 1,47 0.04
DSST symbol scan 144.7 123.0 23 93.7 21.4 27 2.7 1,47 0.11
DSST error 264.3 107.8 23 199.4 47.6 27 5.0 1,47 0.03
Trail A 56.9 29.9 27 36.7 11.9 29 1.1 1,53 0.00
Trail B 153.6 121.1 27 85.1 32.5 29 6.2 1,53 0.02
Trail B minus A 96.7 100.5 27 48.4 25.9 29 4.0 1,53 0.05
REY A1 to A5 39.3 7.7 28 45.1 7.9 30 3.8 1,55 0.06
REY A7 6.6 3.5 28 8.7 2.5 30 3.7 1,55 0.06
REY proportion (%) 61.1 23.4 28 76.8 18.8 30 5.0 1,55 0.03
Fert proportion correct 0.5 0.1 22 0.5 0.1 24 0.1 1,43 0.71
CANTAB Mean SD n Mean SD n F df p
SWM Between errors 4-10 boxes 54.6 37.8 28 38.6 18.4 23 2.7 1,48 0.11
SWM Strategy 35.9 4.5 28 33.9 5.9 23 0.7 1,48 0.42
SWM Strategy 4-10 boxes 46.2 5.6 28 43.1 7.2 23 1.3 1,48 0.25
SWM Within errors 4-10 boxes 11.5 33.0 28 3.8 6.0 23 1.6 1,48 0.22
SSP Span length 4.8 0.9 28 4.9 0.9 23 0.1 1,48 0.79
SSP Total errors 12.3 5.5 28 10.9 4.2 23 0.9 1,48 0.34
PAL Stages completed 7.1 1.6 29 5.4 0.5 23 3.8 1,49 0.06
PAL Stages completed (first trial) 4.4 1.4 29 28.8 0.8 23 6.4 1,49 0.01
PAL Total errors adjusted 59.4 49.6 29 -10.7 23.2 23 6.2 1,49 0.02
AGN Affective response bias Mean 8.3 38.6 27 -10.9 44.6 23 5.2 1,47 0.03
AGN Mean correct latency -0.9 57.9 27 587.0 66.0 23 0.0 1,47 0.98
AGN Median correct latency 589.6 52.4 27 564.3 60.8 23 0.1 1,47 0.79
AGN Total commissions 11.7 6.9 27 8.3 6.1 23 1.7 1,47 0.20
AGN Total omissions 10.0 10.5 27 4.3 4.8 23 4.0 1,47 0.05
Z Scores Mean SD n Mean SD n F df p
Executive working memory -1.2 1.8 29 0.0 0.7 30 6.6 1,57 0.01
Attention and psychomotor speed -2.0 2.8 28 0.0 0.9 30 10.1 1,55 0.00
Short term memory -0.5 0.8 29 0.0 0.8 30 2.1 1,57 0.15
General memory -1.0 1.1 29 0.0 0.8 30 10.4 1,56 0.00
Emotional processing -0.1 0.8 28 0.0 1.0 29 0.0 1,54 0.84
Grand score -0.9 0.9 29 0.0 0.5 30 17.5 1,57 0.00
MRI Volumes Mean SD n Mean SD n t df p
Total hippocampus 5.2 1.1 15 5.3 0.6 15 0.2 28 0.85
Total brain volume 1426.6 131.2 15 1422.4 128.1 15 -0.1 28 0.93
Total WMH volume 14.0 17.3 13 4.6 5.1 14 -2.0 25 0.06
Hippocampus to ICV 0.00364 0.00065 15 0.00374 0.00058 15 0.4 28 0.68
LOG proportion WMH to ICV -2.1 0.5 13 -2.7 0.7 14 -2.5 25 0.02
Healthy controls AnalysisLLD Patients
